Latest AI and machine learning research in other cancers for healthcare professionals.
The urgent need for innovative cancer therapies has driven increasing interest in repurposing drugs originally developed for non-oncological diseases. Several FDA-approved and clinically investigated agents, including mesalamine, celecoxib, gliclazide, metformin, itraconazole, and doxycycline, have shown anticancer potential through diverse mechanisms. However, despite their therapeutic potential,...
PURPOSE: Non-small cell lung cancer (NSCLC) remains a major clinical challenge, with Programmed death-ligand 1 (PD-L1) expression serving as a crucial biomarker to guide immunotherapy. However, its current assessment through invasive biopsies may not capture tumor heterogeneity. This study explores the feasibility of a CT-based radiomics approach, combined with machine learning (ML), as a potentia...
BACKGROUND: Mutations in CTNNB1 are recognized oncogenic drivers of hepatocellular carcinoma (HCC); however, the downstream effector molecules and the...
The field of oncology has witnessed remarkable progress with the integration of high-tech innovations in tumor ablation. Tumor ablation therapies, suc...
OBJECTIVE: Glioblastoma (GBM) is the most aggressive type of intracranial malignant tumor, known for its extremely poor prognosis. Lactylation, a newl...
BACKGROUND: Diagnostics and therapeutics for corneal nerve pathologies are rapidly evolving, with continual advancements in imaging, laser, machine le...
We propose Open Immune Oncology (OpenIO), a framework integrating generative AI and omics to advance precision oncology. By leveraging biological scal...
Cervical intraepithelial neoplasia is the primary type of cervical precancerous lesion; however, manual clinical diagnosis is prone to bias and has li...
BACKGROUND: This study investigates the relationship between histopathological (HP) features, immunohistochemical (IHC) markers, 18F- FDG PET/CT param...
BACKGROUND: Barrett's oesophagus (BE), the precursor to oesophageal adenocarcinoma, progresses through a stepwise dysplastic sequence. Accurate dyspla...
Tumors are highly heterogeneous, and whole-lesion radiomics analysis is a popular method for extracting texture features that reflect this heterogenei...
Chimeric antigen receptor (CAR) T cells have demonstrated curative potential in hematologic cancers and increasing efficacy in solid tumors and non-ma...
OBJECTIVE: To identify the predictors of renal relapse in patients with lupus nephritis (LN) and develop a predictive model. METHODS: The patients wit...
OBJECTIVE: To specify a value operating system (VOS) and its executable metric-the Value Index (VI)-that expresses risk-adjusted outcomes-per-episode-...
OBJECTIVE: 30-day survival after cardiac arrest is low, 12.4% and 36% for out-of-hospital and in-hospital cardiac arrest, respectively. Heart failure ...
BACKGROUND: Limited therapeutic options are available for patients with advanced-stage mycosis fungoides (MF), and the 5-year survival rate is 25%. Du...
BACKGROUND: To develop and validate a deep learning (DL) model based on feature fusion with B-mode ultrasound (BMUS) and contrast enhanced ultrasound ...
This topical Collection presents a series of studies that examine molecular mechanisms, diagnostic approaches, and therapeutic strategies relevant to ...
This study aimed to develop a robust prediction model- using machine-learning algorithms based on the core indicators of the tumor immune microenviron...
Immune-checkpoint inhibitors benefit a subset of patients with advanced cancer, and the metabolic determinants of response remain unclear. Here, using...